Atorvastatin delivered via cardiac homing peptide-functionalized nanoliposomes specifically targeted ischemic myocardium, reducing damage with superior efficacy and safety.
Does atorvastatin delivered by cardiac homing peptide functionalized nanoliposomes improve myocardial damage repair after myocardial infarction?
Targeted delivery of atorvastatin using cardiac homing peptide functionalized nanoliposomes represents a promising preclinical strategy for myocardial repair after infarction.
Absolute Event Rate: 0% vs 0%
Ato@DSPE-PEG-CHP specifically targeted ischemic myocardium, alleviated damage through its anti-inflammatory and antioxidant effects, and demonstrated superior efficacy and safety, presenting a promising treatment strategy for MI.
Yu et al. (Mon,) reported a other. Atorvastatin delivered via cardiac homing peptide-functionalized nanoliposomes specifically targeted ischemic myocardium, reducing damage with superior efficacy and safety.